Skye Bioscience (SKYE) Enterprise Value (QoQ) (2012 - 2026)
Skye Bioscience (SKYE) Enterprise Value (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Skye Bioscience | 11.17 Mn | 11.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.53% |
| Dec 31, 2025 | 27.12% |
| Sep 30, 2025 | 27.32% |
| Jun 30, 2025 | 17.96% |
| Mar 31, 2025 | 13.44% |
| Dec 31, 2024 | -1.49% |
| Sep 30, 2024 | 9.05% |
| Jun 30, 2024 | 11.07% |
| Mar 31, 2024 | -6,533.19% |
| Dec 31, 2023 | 86.17% |
| Sep 30, 2023 | -1,541.51% |
| Jun 30, 2023 | -11,968.10% |
| Mar 31, 2023 | -0.13% |
| Dec 31, 2022 | -0.13% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Sep 30, 2021 | 99.91% |
| Jun 30, 2021 | -113,461.00% |
| Sep 30, 2020 | 95.57% |
| Jun 30, 2020 | 81.82% |